Cramer’s Not on Board With Alcoa, But Likes eBay, Avnet, and These 2 Stocks

Jim Cramer made the following calls on August 13th, 2013. What do you think about his picks?

Alcoa, Inc. (NYSE:AA): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Sell on April 5, 2013. The stock’s 52-week high is $9.93, and its 52-week low is $7.63.

Alcoa was praised and brushed aside all at the same time last night, when Cramer told viewers during the lightning round that “Management is doing a remarkable job, but there is too much aluminum in the world.” Alcoa lost 11 cents per share in the second quarter this year.

aa-08142013

eBay Inc. (NASDAQ:EBAY): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on June 17, 2013. The stock’s 52-week high is $58.04, and its 52-week low is $44.95.

eBay is another iconic American company that Cramer will do better once Europe really starts to grow. In the second quarter company enabled commerce was up 21 percent from last year and $640 million in revenue was taken in by the e-commerce giant.

ebay-08142013

Avnet Inc. (NYSE:AVT): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on June 18, 2013. The stock’s 52-week high is $39.86, and its 52-week low is $25.41.

Rick Hamada, chairman and CEO of Avnet sat down last night to talk to Cramer about his business. Hamada pointed to strengthening sales in Europe and in Asia as well as growing margins are reasons for optimism.

avt-08142013

Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on February 19, 2013. The stock’s 52-week high is $10.57, and its 52-week low is $6.95.

Cramer feels that Banco Bilbao is cheap at its current price. Chief Economist Nathaniel Karp commented on the banking landscape in the global economy and how Banco Bilbao might survive, or thrive, in a recent note, “To succeed in this new hyperconnected and competitive environment, banks will have to follow a customer-centric approach and offer simple, user-friendly and effective products, with a high level of transparency and security,” he said.

bbva-08142013

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Sell on January 14, 2010. The stock’s 52-week high is $6.47, and its 52-week low is $1.08.

One of only a handful of stocks scorned by Cramer last night, he said simply that, “It is not my kind of name. Forget it.” According to the conference call for the second quarter, the company has enough cash to operate into 2014.

bcrx-08142013

Don’t Miss: Tesla Moves to Upset the Status Quo, Again.

More Articles About:   , , , , , ,  

More from The Cheat Sheet